相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between mortality risk and the number, location, and sequence of subsequent fractures in the elderly
S-B Lee et al.
OSTEOPOROSIS INTERNATIONAL (2021)
Effectiveness of parathyroid hormone (PTH) analogues on fracture healing: a meta-analysis
K. Eastman et al.
OSTEOPOROSIS INTERNATIONAL (2021)
Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries
Azeem Tariq Malik et al.
SPINE JOURNAL (2020)
Osteoporosis treatment gap in a prospective cohort of volunteer women
L. Iconaru et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Timing of anti-osteoporosis medications initiation after a hip fracture affects the risk of subsequent fracture: A nationwide cohort study
Chen-Yu Wang et al.
BONE (2020)
Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip fracture in Japan
Shinichi Nakatoh et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2020)
Incidence of clinical vertebral fractures and hip fractures of the elderly (65 years or over) population-large-scale data analysis using claim database in Kure City, Hiroshima, Japan
Takahiko Hamasaki et al.
ARCHIVES OF OSTEOPOROSIS (2020)
Rates of osteoporosis screening and treatment following vertebral fracture
David W. Barton et al.
SPINE JOURNAL (2019)
Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: a meta-analysis of randomized controlled trials
Yuan-Zhe Jin et al.
BMC MUSCULOSKELETAL DISORDERS (2019)
Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015
J. Tamaki et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Influence of bone densitometry on the anti-osteoporosis treatment after fragility hip fracture
Peiwen Wang et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2019)
Improvement in the rate of inadequate pharmaceutical treatment by orthopaedic surgeons for the prevention of a second fracture over the last 10 years
Kousuke Iba et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2018)
Factors related with osteoporosis treatment in postmenopausal women
Lia Mara Montagner Rossi et al.
MEDICINE (2018)
Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures An Instrumental Variable Analysis
Rishi J. Desai et al.
JAMA NETWORK OPEN (2018)
Characteristics and outcomes of hospitalised patients with vertebral fragility fractures: a systematic review
Terence Ong et al.
AGE AND AGEING (2018)
Osteoporosis-Related Health Services Utilization Following First Hip Fracture Among a Cohort of Privately-Insured Women in the United States, 2008-2014: An Observational Study
Catherine W. Gillespie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Reasons for Not Treating Women with Postmenopausal Osteoporosis with Prescription Medications: Physicians' and Patients' Perspectives
Jessica Papadopoulos Weaver et al.
JOURNAL OF WOMENS HEALTH (2017)
Access to Anti-osteoporosis Medication after Hip Fracture in Korean Elderly Patients
Yun Mi Yu et al.
MATURITAS (2017)
Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis
T. Saito et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Diagnosis and Treatment of Osteoporosis Before and After Fracture: A Side-by-Side Analysis of Commercially Insured and Medicare Advantage Osteoporosis Patients
Jessica Weaver et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2017)
Second fractures among older adults in the year following hip, shoulder, or wrist fracture
J. P. W. Bynum et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Hip fracture incidence in Japan: Estimates of new patients in 2012 and 25-year trends
H. Orimo et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Use of Osteoporosis Medications after Hospitalization for Hip Fracture: A Cross-national Study
Seoyoung C. Kim et al.
AMERICAN JOURNAL OF MEDICINE (2015)
Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis
Y. Tsukutani et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011
Daniel H. Solomon et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Patient perceptions of provider barriers to post-fracture secondary prevention
J. E. M. Sale et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA
A. Wilk et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Diagnostic criteria for primary osteoporosis: year 2012 revision
Satoshi Soen et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2013)
Long-term mortality following fractures at different skeletal sites: a population-based cohort study
L. J. Melton et al.
OSTEOPOROSIS INTERNATIONAL (2013)
The Risk of a Second Hip Fracture in Patients after Their First Hip Fracture
Hiroshi Hagino et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Osteoporosis and polypharmacy
M. Gosch et al.
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE (2012)
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study
George Ioannidis et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture
Veronique Rabenda et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2008)
Patient adherence to osteoporosis medications - Problems, consequences and management strategies
Alexandra Papaioannou et al.
DRUGS & AGING (2007)
分享论文
